We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
CLINICAL TRIALS NEWS.
- Abstract
The article presents news briefs relevant to clinical trials in the pharmaceutical industry in the United States compiled as of August 2006. Phase IV trial of Kos Pharmaceuticals' Niaspan has been administered to patients at high risk for heart attack, in combination with a low to moderate dose of Lipitor or Crestor. The New York-based companies OSI Pharmaceuticals and Pfizer have initiated a 54-week Phase IV trial of Macugen as maintenance therapy for patients with neovascular disease.
- Subjects
NEW York (State); UNITED States; CLINICAL trials; PHARMACEUTICAL industry; MYOCARDIAL infarction; KOS Pharmaceuticals Inc.; OSI Pharmaceuticals Inc.; PFIZER Inc.
- Publication
Applied Clinical Trials, 2006, Vol 15, Issue 8, p16
- ISSN
1064-8542
- Publication type
Article